(R)-Oxiracetam structure
|
Common Name | (R)-Oxiracetam | ||
|---|---|---|---|---|
| CAS Number | 68252-28-8 | Molecular Weight | 158.155 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 494.6±40.0 °C at 760 mmHg | |
| Molecular Formula | C6H10N2O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 252.9±27.3 °C | |
Use of (R)-Oxiracetam(R)-Oxiracetam is the (R)-enantiomer of the nootropic drug oxiracetam. Oxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.IC50 value:Target: nootropic drugOxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.[1][2] Several animal studies suggest that the substance is safe even when high doses are consumed for a long period of time.[medical citation needed] However, the mechanism of action of the racetam drug family is still a matter of research. Oxiracetam is not approved by Food and Drug Administration for any medical use in the United States. |
| Name | (R)-oxiracetam |
|---|---|
| Synonym | More Synonyms |
| Description | (R)-Oxiracetam is the (R)-enantiomer of the nootropic drug oxiracetam. Oxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.IC50 value:Target: nootropic drugOxiracetam (ISF 2522) is a nootropic drug of the racetam family and stimulant.[1][2] Several animal studies suggest that the substance is safe even when high doses are consumed for a long period of time.[medical citation needed] However, the mechanism of action of the racetam drug family is still a matter of research. Oxiracetam is not approved by Food and Drug Administration for any medical use in the United States. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 494.6±40.0 °C at 760 mmHg |
| Molecular Formula | C6H10N2O3 |
| Molecular Weight | 158.155 |
| Flash Point | 252.9±27.3 °C |
| Exact Mass | 158.069138 |
| PSA | 83.63000 |
| LogP | -2.48 |
| Vapour Pressure | 0.0±2.9 mmHg at 25°C |
| Index of Refraction | 1.570 |
| InChIKey | IHLAQQPQKRMGSS-SCSAIBSYSA-N |
| SMILES | NC(=O)CN1CC(O)CC1=O |
| 2-[(4R)-4-hydroxy-2-oxopyrrolidin-1-yl]acetamide |
| 1-Pyrrolidineacetamide, 4-hydroxy-2-oxo- |
| 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide |
| UNII:P7U817352G |
| (R)-2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide |
| 2-(4-Hydroxypyrrolidin-2-on-1-yl)acetamide |
| L-oxiracetam |
| oxiracetam |
| (R)-4-hydroxy-2-oxopyrrolidineacetamide |
| (R)-4-hydroxy-2-oxo-1-pyrrolidineacetamide |
| R-oxiracetam |
| 2-[(4R)-4-Hydroxy-2-oxo-1-pyrrolidinyl]acetamide |
| 2-(4-Hydroxy-2-oxo-1-pyrrolidinyl)acetamide |
| 1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-, (4R)- |
| (4R)-(+)-oxiracetam |